Emergency preservation and
resuscitation (EPR) is a new approach for
resuscitation of
exsanguination cardiac arrest (CA) victims. EPR uses a cold aortic flush to induce deep hypothermic preservation during no-flow to buy time for transport and damage control surgery, followed by
resuscitation with
cardiopulmonary bypass (CPB). We reported previously that 20-60 min EPR in rats was associated with intact outcome, while 75 min EPR resulted in high mortality and neurological impairment in survivors. The delta
opioid agonist
DADLE ([D-Ala(2),D-Leu(5)]-
enkephalin) was shown previously to be protective against
ischemia-reperfusion injury in multiple organs, including brain. We hypothesized that
DADLE could augment neurological outcome after EPR in rats. After rapid lethal
hemorrhage, EPR was initiated by perfusion with
ice-cold
crystalloid to induce
hypothermia (15 degrees C). After 75 min EPR,
resuscitation was attempted with CPB. After randomization, three groups were studied (n=10 per group):
DADLE 0mg/kg (D0), 4 mg/kg (D4) or 10mg/kg (D10) added to the flush and during reperfusion. Survival, overall performance category (OPC; 1=normal, 5=death), neurological deficit score (
NDS; 0-10% normal, 100%=max deficit), and histological damage score (HDS) were assessed in survivors on day 3. In D0 group, 2/10 rats survived, while in D4 and D10 groups, 4/10 and 5/10 rats survived, respectively (p=NS). Survival time (h) was 26.7+/-28.2 in D0, 36.3+/-31.9 in D4 and 47.1+/-30.3 in D10 groups, respectively (p=0.3). OPC,
NDS and HDS were not significantly different between groups. In conclusion,
DADLE failed to confer benefit on functional or histological outcome in our model of prolonged rat EPR.